Cargando…

Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site

P38α mitogen-activated protein kinase (p38α MAPK), one of the p38 MAPK isoforms participating in a signaling cascade, has been identified for its pivotal role in the regulation of physiological processes such as cell proliferation, differentiation, survival, and death. Herein, by shedding light on d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suriya, Utid, Mahalapbutr, Panupong, Rungrotmongkol, Thanyada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321129/ https://www.ncbi.nlm.nih.gov/pubmed/35890356 http://dx.doi.org/10.3390/pharmaceutics14071461

Ejemplares similares

Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights
por: Suriya, Utid, et al.
Publicado: (2022)

In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach
por: Thirunavukkarasu, Muthu Kumar, et al.
Publicado: (2021)

In vitro and in silico studies of 7′′,8′′-buddlenol D anti-inflammatory lignans from Carallia brachiata as p38 MAP kinase inhibitors
por: Nalinratana, Nonthaneth, et al.
Publicado: (2023)

In Silico and In Vitro Study of Janus Kinases Inhibitors from Naphthoquinones
por: Sanachai, Kamonpan, et al.
Publicado: (2023)

Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2′-O-Methyltransferase
por: Mahalapbutr, Panupong, et al.
Publicado: (2020)

Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies
por: Aiebchun, Thitinan, et al.
Publicado: (2021)

Enhancing solubility and stability of sorafenib through cyclodextrin-based inclusion complexation: in silico and in vitro studies
por: Aman, Aamir, et al.
Publicado: (2023)

Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2020)

Butoxy Mansonone G Inhibits STAT3 and Akt Signaling Pathways in Non-Small Cell Lung Cancers: Combined Experimental and Theoretical Investigations
por: Mahalapbutr, Panupong, et al.
Publicado: (2019)

Fisetin glycosides synthesized by cyclodextrin glycosyltransferase from Paenibacillus sp. RB01: characterization, molecular docking, and antioxidant activity
por: Lorthongpanich, Nattawadee, et al.
Publicado: (2022)

Enhanced Solubility and Anticancer Potential of Mansonone G By β-Cyclodextrin-Based Host-Guest Complexation: A Computational and Experimental Study
por: Mahalapbutr, Panupong, et al.
Publicado: (2019)

Aurisin A Complexed with 2,6-Di-O-methyl-β-cyclodextrin Enhances Aqueous Solubility, Thermal Stability, and Antiproliferative Activity against Lung Cancer Cells
por: Charoenwongpaiboon, Thanapon, et al.
Publicado: (2022)

Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein
por: Darai, Nitchakan, et al.
Publicado: (2022)

Sulfonylated Indeno[1,2-c]quinoline Derivatives as Potent EGFR Tyrosine Kinase Inhibitors
por: Hengphasatporn, Kowit, et al.
Publicado: (2023)

Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases
por: Sanachai, Kamonpan, et al.
Publicado: (2022)

Atomistic mechanisms underlying the activation of the G protein-coupled sweet receptor heterodimer by sugar alcohol recognition
por: Mahalapbutr, Panupong, et al.
Publicado: (2019)

Publisher Correction: Atomistic mechanisms underlying the activation of the G protein-coupled sweet receptor heterodimer by sugar alcohol recognition
por: Mahalapbutr, Panupong, et al.
Publicado: (2019)

Discovery of Anilino-1,4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling
por: Mahalapbutr, Panupong, et al.
Publicado: (2022)

Discovery of Novel Naphthoquinone–Chalcone Hybrids as Potent FGFR1 Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling
por: Leechaisit, Ronnakorn, et al.
Publicado: (2023)

Discovery of Novel EGFR Inhibitor Targeting Wild-Type and Mutant Forms of EGFR: In Silico and In Vitro Study
por: Todsaporn, Duangjai, et al.
Publicado: (2023)

Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
por: Somboon, Tuanjai, et al.
Publicado: (2021)

Discovery of JAK2/3 Inhibitors from Quinoxalinone-Containing Compounds
por: Sanachai, Kamonpan, et al.
Publicado: (2022)

p38γ and p38δ Mitogen Activated Protein Kinases (MAPKs), New Stars in the MAPK Galaxy
por: Escós, Alejandra, et al.
Publicado: (2016)

Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3
por: Bassi, Rekha, et al.
Publicado: (2017)

New aspects of p38 mitogen activated protein kinase (MAPK) biology in lung inflammation
por: Newton, Robert, et al.
Publicado: (2006)

The Rational Design of Specific Peptide Inhibitor against p38α MAPK at Allosteric-Site: A Therapeutic Modality for HNSCC
por: Gill, Kamaldeep, et al.
Publicado: (2014)

Identification of a Novel Inhibitory Allosteric Site in p38α
por: Gomez-Gutierrez, Patricia, et al.
Publicado: (2016)

Design of electron-donating group substituted 2-PAM analogs as antidotes for organophosphate insecticide poisoning
por: Kongkaew, Nalinee, et al.
Publicado: (2023)

Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i)
por: Ganguly, Payal, et al.
Publicado: (2023)

p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma
por: Yang, Ling, et al.
Publicado: (2019)

In Vitro and In Silico Study on the Molecular Encapsulation of α-Tocopherol in a Large-Ring Cyclodextrin
por: Sangkhawasi, Mattanun, et al.
Publicado: (2023)

P38 Mitogen-activated Protein Kinase and Parkinson’s Disease
por: He, Jianying, et al.
Publicado: (2018)

Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer′s Disease
por: Son, Seung Hwan, et al.
Publicado: (2023)

Bmp4 in Zebrafish Enhances Antiviral Innate Immunity through p38 MAPK (Mitogen-Activated Protein Kinases) Pathway
por: Chen, Lihui, et al.
Publicado: (2023)

Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer
por: Donohoe, Fionán, et al.
Publicado: (2020)

Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link
por: Chen, Chaobo, et al.
Publicado: (2019)

Mechanism and consequence of the autoactivation p38α Mitogen-activated Protein Kinase promoted by TAB1
por: DeNicola, Gian Felice, et al.
Publicado: (2013)

The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS
por: Chung, S-H, et al.
Publicado: (2015)

Roles of p38α mitogen‐activated protein kinase in mouse models of inflammatory diseases and cancer
por: Gupta, Jalaj, et al.
Publicado: (2015)

Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction
por: Chen, Hongmei, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_g2irek5h58pmteq5t65pv437je